{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:29:07Z","timestamp":1754152147490,"version":"3.41.2"},"reference-count":151,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004964","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T10:08:51Z","timestamp":1097748531000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Amphetamines for schizophrenia"],"prefix":"10.1002","volume":"2010","author":[{"given":"Sue","family":"Nolte","sequence":"first","affiliation":[{"name":"Bridge House; Adult Psychology Service; Balm Road Leeds West Yorkshire UK LS10 2TP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wong","sequence":"additional","affiliation":[{"name":"University of Leeds; Department of Psychiatry and Behavioural Sciences; Leeds UK LS2 9JT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Latchford","sequence":"additional","affiliation":[{"name":"University of Leeds; Leeds Institute of Health Sciences; 101 Clarendon Road Charles Thackrah Building Leeds West Yorkshire UK LS2 9LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Boyle","sequence":"additional","affiliation":[{"name":"50A Street Lane Leeds West Yorkshire UK LS8 2ET"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adaeze","family":"Anaenugwu","sequence":"additional","affiliation":[{"name":"Duncan Macmillan House; Division of Psychiatry; Porchester Road Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,19]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000118564","article-title":"Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients","volume":"21","author":"Mathew","year":"1989","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1002\/14651858.CD004964-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1965.03090040019006","article-title":"Failure of dextroamphetamine sulphate to influence eating and sleeping patterns in obese schizophrenic patients","volume":"193","author":"Modell","year":"1965","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002826-200105000-00004","article-title":"Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol","volume":"24","author":"Angrist","year":"2001","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02246180","article-title":"Amphetamine and negative symptoms of schizophrenia","volume":"123","author":"Sanfilipo","year":"1996","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00177923","article-title":"Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography","volume":"92","author":"Wolkin","year":"1987","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002826-200105000-00004","article-title":"Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol","volume":"24","author":"Angrist","year":"2001","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02246180","article-title":"Amphetamine and negative symptoms of schizophrenia","volume":"123","author":"Sanfilipo","year":"1996","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004964-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-3223(94)90629-7","article-title":"Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology","volume":"36","author":"Wolkin","year":"1994","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0009|cit9","first-page":"187","article-title":"Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment","volume":"29","author":"Aman","year":"1985","journal-title":"Journal of Mental Deficiency Research"},{"issue":"5325","key":"10.1002\/14651858.CD004964-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/234152a0","article-title":"Comparative psychomimetic effects of stereoisomers of amphetamine","volume":"234","author":"Angrist","year":"1971","journal-title":"Nature"},{"issue":"7","key":"10.1002\/14651858.CD004964-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1176\/ajp.131.7.817","article-title":"The antagonism of amphetamine induced symptomatology by a neuroleptic","volume":"131","author":"Angrist","year":"1974","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00433802","article-title":"Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia","volume":"72","author":"Angrist","year":"1980","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00427592","article-title":"Responses to apomorphine, amphetamine and neuroleptics in schizophrenic subjects","volume":"67","author":"Angrist","year":"1980","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002826-200105000-00004","article-title":"Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol","volume":"24","author":"Angrist","year":"2001","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00432248","article-title":"Partial improvement in negative schizophrenic symptoms after amphetamine","volume":"78","author":"Angrist","year":"1982","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002826-200105000-00004","article-title":"Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol","volume":"24","author":"Angrist","year":"2001","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD004964-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Baker A Lewin T Reichler H Clancy R Carr V Garrett R Sly K Devir H Terry M Evaluation of a motivational interview for substance use within psychiatric inpatient services Unpublished 2002 2002 77167227","DOI":"10.1046\/j.1360-0443.2002.00178.x"},{"issue":"4","key":"10.1002\/14651858.CD004964-BIB0018|cit18","first-page":"262","article-title":"Methylphenidate and neuroleptic effects on oral word production in schizophrenia","volume":"5","author":"Bilder","year":"1992","journal-title":"Neuropsychiatry Neuropsychology and Behavioral Neurology"},{"key":"10.1002\/14651858.CD004964-BIB0019|cit19","first-page":"1123","article-title":"Experimental studies of the mental speed of schizophrenics. I. Effects of a stimulant and a depressant drug","volume":"104","author":"Broadhurst","year":"1958","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD004964-BIB0020|cit20","unstructured":"Brown ES Nejtek VA Perantie DC Neuroleptics and quetiapine in psychiatric illnesses with comorbid stimulant abuse International Journal of Neuropsychopharmacology (Abstracts of the 23rd Congress of the Collegium Internationale Neuro-Psychopharmacologicum; 2002 Jun 23-27; Montreal, Canada) 2002 S157"},{"issue":"1,2","key":"10.1002\/14651858.CD004964-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0920-9964(95)95446-G","article-title":"Dopamine agents for the treatment of the negative symptoms of schizophrenia","volume":"15","author":"Buchanan","year":"1995","journal-title":"Schizophrenia Research"},{"issue":"12","key":"10.1002\/14651858.CD004964-BIB0022|cit22","first-page":"759","article-title":"Acute responses of schizophrenic children to a sedative and a \"stimulating\" neuroleptic: A pharmacologic yardstick","volume":"14","author":"Campbell","year":"1972","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0023|cit23","first-page":"70","article-title":"Levodopa and levoamphetamine: a crossover study in young schizophrenic children","volume":"19","author":"Campbell","year":"1976","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-7138(09)60909-2","article-title":"Drugs in aggressive behavior","volume":"21","author":"Campbell","year":"1982","journal-title":"Journal of the American Academy of Child Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004964-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-199208000-00010","article-title":"Methylphenidate augmentation therapy in schizophrenia","volume":"12","author":"Carpenter","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/ajp.155.1.70","article-title":"Spontaneous dyskinesia in subjects with schizophrenia spectrum personality","volume":"155","author":"Cassady","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0027|cit27","unstructured":"Cassady SL Adams HM Kunkel RS Sherr JD Moran MJ Thaker GK Lack of response to amphetamine in schizophrenia spectrum personality Schizophrenia Research (Abstracts of The 7th International Congress on Schizophrenia Research; 1999 Apr 17-21; Santa Fe, USA) 1999 306 81175504"},{"issue":"1,2","key":"10.1002\/14651858.CD004964-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-9964(95)95449-J","article-title":"Stereotypic response to amphetamine in spectrum personality","volume":"15","author":"Cassady","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004964-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1974.tb08044.x","article-title":"A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study","volume":"249","author":"Cesarec","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0030|cit30","first-page":"21","article-title":"A controlled study of tryptophan-benserazide in schizophrenia","volume":"2","author":"Chouinard","year":"1978","journal-title":"Communications in Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004964-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00006842-197309000-00003","article-title":"Effects of amphetamine and barbiturate on body experience","volume":"35","author":"Clausen","year":"1973","journal-title":"Psychosomatic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004964-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/026988110001400406","article-title":"Individual differences in mood reactions to d-amphetamine: a test of three personality factors","volume":"14","author":"Corr","year":"2000","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1964.tb00396.x","article-title":"The effects of depressant and stimulant drugs on the relationship between reaction time and stimulus light intensity","volume":"3","author":"Costello","year":"1964","journal-title":"British Journal of Social and Clinical Psychology"},{"issue":"7","key":"10.1002\/14651858.CD004964-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1523\/JNEUROSCI.11-07-01907.1991","article-title":"The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia","volume":"11","author":"Daniel","year":"1991","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/ajp.148.1.78","article-title":"Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia","volume":"148","author":"Goldberg","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Llewellyn B Bigelow MD Goldberg TE Daniel DG Klienman JE Acute amphetamine effect on neuropsychological testing in chronic schizophrenia Schizophrenia Reseach (Winter Workshop on Schizophrenia, 1988, Badagastein, Austria) 1988 249 50","DOI":"10.1016\/0920-9964(88)90199-5"},{"issue":"8","key":"10.1002\/14651858.CD004964-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1176\/ajp.130.8.922","article-title":"Methylphenidate in tardive dyskinesia","volume":"130","author":"Fann","year":"1973","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/ajp.123.1.32","article-title":"Long-term prognosis and the response of schizophrenic children to drug therapy: a controlled study of trifluoperazine","volume":"123","author":"Fish","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-3956(67)90016-7","article-title":"The role of personality variables in response to chlorpromazine, dextroamphetamine and placebo","volume":"5","author":"Forrest","year":"1967","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD004964-BIB0040|cit40","unstructured":"Gefvert O Lundberg T Hagstrom P Lindstrom L Sonesson C Waters N Carlsson A Tedroff J Dopamine stabilizers;pharmacokinetics, antipsychotic effects and safety International Journal of Neuropsychopharmacology (Abstracts of the 23rd Congress of the Collegium Internationale Neuro-Psychopharmacologicum; 2002 Jun 23-27; Montreal, Canada) 2002 S176"},{"issue":"20","key":"10.1002\/14651858.CD004964-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/0024-3205(78)90596-9","article-title":"Pimozide attentuates d-amphetamine-induced sleep changes in man.","volume":"22","author":"Gillin","year":"1978","journal-title":"Life Sciences"},{"issue":"2,3","key":"10.1002\/14651858.CD004964-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0920-9964(96)85404-1","article-title":"Increased schizotypy scores in normal subjects following the oral administration of D-amphetamine","volume":"18","author":"Gray","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004964-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Gross G Bailey P Bialojan S Garcia Ladona FJ Geyer M Greger G Luthringer R P Macher JAU Needham P M\u00fcller B Rendenbach Steiner LU 111995, a dopamine D4 AND 5 hydroxytryptamine 2A antagonist: pharmacological characterisation and first clinical experience 11th Congress of The European College of Neuropsychopharmacology; 1998 Oct 31- Nov 4; Paris, France 1998","DOI":"10.1016\/S0924-977X(98)80453-7"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0044|cit44","first-page":"77","article-title":"Clozapine - antipsychotic activity in treatment-resistant schizophrenics","volume":"1","author":"Honigfeld","year":"1984","journal-title":"Advances in Therapy"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1973.01750320023004","article-title":"Provocation of schizophrenic symptoms by intravenous administration of methylphenidate","volume":"28","author":"Janowsky","year":"1973","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0046|cit46","first-page":"15","article-title":"Proceedings: effect of intravenous d amphetamine, l amphetamine and methylphenidate in schizophrenics","volume":"10","author":"Janowski","year":"1974","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004964-BIB0047|cit47","first-page":"317","article-title":"Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics","volume":"12","author":"Janowsky","year":"1974","journal-title":"Advances in Biochemical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archpsyc.1976.01770030024003","article-title":"Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms","volume":"33","author":"Janowsky","year":"1976","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00428034","article-title":"Comparison of oral and intravenous methylphenidate","volume":"59","author":"Janowsky","year":"1978","journal-title":"Psychopharmacology Berlin"},{"key":"10.1002\/14651858.CD004964-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Jauhar P Suddle A Skelton F Smith G The prevalence of substance abuse and dual diagnosis within an in-patient population serving the end of Glasgow 7th World Congress of Biological Psychiatry; 2001 Jul 1-6; Berlin, Germany 2001","DOI":"10.3109\/15622970009150597"},{"key":"10.1002\/14651858.CD004964-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00005053-196810000-00010","article-title":"The effects of chlorpromazine and methamphetamine on visual signal-from-noise detection","volume":"147","author":"Kopell","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"12","key":"10.1002\/14651858.CD004964-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archpsyc.1976.01770120029002","article-title":"Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine","volume":"33","author":"Kornetsky","year":"1976","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002130051040","article-title":"Effects of prepulses and d amphetamine on performance and event related potential measures on an auditory discrimination task","volume":"145","author":"Kroner","year":"1999","journal-title":"Psychopharmacology Berlin"},{"key":"10.1002\/14651858.CD004964-BIB0054|cit54","unstructured":"Krystal JH D'Souza DC Belger A Cassello K Madonick S Sernyak M Abi-Saab W Amphetamine pretreatment reduces attention deficits, but not psychosis, produced by ketamine, produced in healthy human subjects Schizophrenia Research (Abstracts of The 7th International Congress on Schizophrenia Research; 1999 Apr 17-21; Santa Fe, USA) 1999 309 10"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0920-9964(00)90891-0","article-title":"Ketamine and amphetamine interactions in healthy humans: further insights into glutamate dopamine interactions","volume":"235","author":"Krystal","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0057|cit56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002130050190","article-title":"Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man","volume":"129","author":"Kumari","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD004964-BIB0056|cit57","doi-asserted-by":"crossref","unstructured":"Kumari V Corr PJ Mulligan OF Cotter PA Checkley SA Gray JA Effects of acute administration of D-amphetamine and haloperidol on procedural learning in man Schizophrenia Research (6th International Congress on Schizophrenia Research; 1997 Apr 12-16; Colorado, USA) 1997 110 77064771","DOI":"10.1016\/S0920-9964(97)82308-0"},{"issue":"7","key":"10.1002\/14651858.CD004964-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00008877-199811000-00012","article-title":"Effects of single oral administrations of haloperidol and d amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers","volume":"9","author":"Kumari","year":"1998","journal-title":"Behavioural Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004964-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1002\/14651858.CD004964-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerised tomography imaging of amphetamine induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laurelle","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0061|cit61","first-page":"55","article-title":"Natural human leukocyte interferon in the treatment of schizophrenia","volume":"5","author":"Leszek","year":"1991","journal-title":"European Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD004964-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-3223(93)90192-G","article-title":"Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls","volume":"34","author":"Levy","year":"1993","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/npp.1994.40","article-title":"Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia","volume":"11","author":"Lieberman","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004964-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1176\/ajp.141.5.633","article-title":"Methylphenidate challenge as a predictor of relapse in schizophrenia","volume":"141","author":"Lieberman","year":"1984","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004964-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1987.01800190013002","article-title":"Prediction of relapse in schizophrenia","volume":"44","author":"Lieberman","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0066|cit66","first-page":"845","article-title":"Prediction of relapse in schizophrenia","volume":"22","author":"Lieberman","year":"1986","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0920-9964(94)90096-5","article-title":"Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals","volume":"13","author":"Malaspina","year":"1994","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/026988110101500211","article-title":"The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers","volume":"15","author":"McCartan","year":"2001","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cpt19623116","article-title":"Drug therapy in depressions: Controlled evaluation of impramine, isocarboxazide, dextroamphetamine-amobarbital, and placebo","volume":"3","author":"Overall","year":"1961","journal-title":"Clincal Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-3223(89)90165-0","article-title":"Amphetamine challenge test, response to treatment, and lateral ventricle size in schizophrenia","volume":"25","author":"Pandurangi","year":"1989","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1207\/s15327752jpa6403_5","article-title":"Amphetamines on Rorschach measures in normal subjects","volume":"64","author":"Perry","year":"1995","journal-title":"Journal of Personality Assessment"},{"key":"10.1002\/14651858.CD004964-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1176\/ajp.121.12.1147","article-title":"Time-series frequency analysis and electrogenesis of the EEG's of normals and psychotics before and after drugs","volume":"122","author":"Pfeiffer","year":"1965","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00005053-196805000-00005","article-title":"Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background","volume":"146","author":"Rappaport","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02244317","article-title":"Mood responses of remitted schizophrenics to methylphenidate infusion","volume":"16","author":"Robinson","year":"1991","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-1781(92)90090-P","article-title":"Response of plasma beta endorphin immunoreactivity to d amphetamine and placebo in schizophrenic patients","volume":"7","author":"Schulz","year":"1982","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-1781(90)90130-W","article-title":"Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone","volume":"32","author":"Sharma","year":"1990","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1002\/14651858.CD004964-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-3223(91)90307-8","article-title":"Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients","volume":"30","author":"Sharma","year":"1991","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0078|cit78","unstructured":"Sherr JD Cassday SL Ross DR Thaker GK Amphetamine challenge asymmetrically disrupts eye movements in schizophrenia spectrum personality Schizophrenia Research (Abstracts of The 7th International Congress on Schizophrenia Research; 1999 Apr 17-21; Santa Fe, USA) 1999 315"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01250567","article-title":"Effect of apomorphine on schizophrenic symptoms","volume":"40","author":"Smith","year":"1977","journal-title":"Journal of Neural Transmission"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0080|cit80","first-page":"88","article-title":"Psychotropic actions of pyrovalerone, placebo, and environmental therapy and role of mental state in patients detained in a mental hospital on a court order (German)","volume":"47","author":"Soederholm","year":"1976","journal-title":"Nervenarzt"},{"issue":"8","key":"10.1002\/14651858.CD004964-BIB0081|cit81","first-page":"526","article-title":"Clinical studies with propericiazine (RP. 8909)","volume":"28","author":"StJean","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD004964-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0006-3223(97)00052-8","article-title":"Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: Implications for a sensitization model of psychosis in humans","volume":"42","author":"Strakowski","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1176\/ajp.139.8.991","article-title":"d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia","volume":"139","author":"Kammen","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0084|cit84","first-page":"655","article-title":"Amphetamine-induced catecholamine activation in schizophrenia and depression: behavioral and physiological effects","volume":"16","author":"Kammen","year":"1977","journal-title":"Advances in Biochemical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0085|cit85","first-page":"233","article-title":"Prediction of early relaspe after pimozide discontinuation by response to d-amphetamine during pimozide tretament","volume":"17","author":"Kammen","year":"1982","journal-title":"Biological Pyschiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archpsyc.1982.04290030017003","article-title":"Long-term pimozide pretreatment differentially affects behavioural responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia.","volume":"39","author":"Kammen","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.1982.04290030011002","article-title":"Antipsychotic effects of pimozide in schizophrenia. Treatment reponse prediction with acute dextroamphetamine response","volume":"39","author":"Kammen","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archpsyc.1980.01780160057006","article-title":"Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients","volume":"37","author":"Kammen","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"14","key":"10.1002\/14651858.CD004964-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0024-3205(78)90130-3","article-title":"d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment","volume":"23","author":"Kammen","year":"1978","journal-title":"Life Sciences"},{"issue":"3","key":"10.1002\/14651858.CD004964-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(81)90033-0","article-title":"Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients","volume":"4","author":"Kammen","year":"1981","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00431789","article-title":"Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia","volume":"87","author":"Kammen","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004850-198804000-00002","article-title":"Dextro-amphetamine diminishes negative symptoms in schizophrenia","volume":"3","author":"Kammen","year":"1988","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004964-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1176\/ajp.117.2.156-a","article-title":"Clinical observations on ritalin HCL (methylphenidylacetate) injectable, multiple dose vial","volume":"117","author":"Witton","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-1781(81)90006-8","article-title":"Autonomic effects of dextroamphetamine in normal men: implications for hyperactivity and schizophrenia","volume":"4","author":"Zahn","year":"1981","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD004964-BIB0095|cit95","unstructured":"Zemishlany Z Aizenberg D Weizman A Effects of agents active at the dopaminergic system on sexual function 9th Congress of the Association of European Psychiatrists; 1998 Sep 20-24; Copenhagen, Denmark 1998"},{"issue":"1,2","key":"10.1002\/14651858.CD004964-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-9964(95)95530-M","article-title":"NMDA receptor augmentation therapy in schizophrenia","volume":"15","author":"Zylberman","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004964-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1749-6632.1995.tb17508.x","article-title":"Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia","volume":"757","author":"Zylberman","year":"1995","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD004964-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Barch DM Carter CS Braver TS Cohen JD The effects of D-amphetamine on working memory and language deficits in schizophrenia Schizophrenia Research (6th International Congress on Schizophrenia Research; 1997 Apr 12-16; Colorado, USA) 1997 129","DOI":"10.1016\/S0920-9964(97)82363-8"},{"key":"10.1002\/14651858.CD004964-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.117.11.997","article-title":"Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine","volume":"117","author":"Casey","year":"1961","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004964-BIB0100|cit100","first-page":"352","article-title":"Effect of a single administration of amphetamine on vestibular caloric reaction in healthy volunteers","volume":"27","author":"Filipova","year":"1978","journal-title":"Ceskoslovenska Otolaryngologie"},{"issue":"11","key":"10.1002\/14651858.CD004964-BIB0101|cit101","first-page":"1705","article-title":"Use of psychological methods for studying the particular psychotropic action of various psychopharmacologic drugs","volume":"72","author":"Os'makova","year":"1972","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"key":"10.1002\/14651858.CD004964-BIB0102|cit102","first-page":"225","article-title":"A rating scale for emotional blunting","volume":"135","author":"Abrams","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information.","volume":"313","author":"Altman","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004964-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia: A longitudinal study of Swedish conscripts.","volume":"2 8574","author":"Andreasson","year":"1987","journal-title":"The Lancet"},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Third Edition","year":"1980","author":"American Psychiatric Association","key":"10.1002\/14651858.CD004964-BIB0105|cit105"},{"key":"10.1002\/14651858.CD004964-BIB0106|cit106","article-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM III-R)","volume-title":"American Psychiatric Association","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD004964-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement.","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004964-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0272-7358(99)00033-1","article-title":"Substance use disorders in schizophrenia. Review, integration and proposed model.","volume":"20","author":"Blanchard","year":"2000","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD004964-BIB0109|cit109","first-page":"600","article-title":"Statistics notes. Trials randomised in clusters.","volume":"7108","author":"Bland","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004964-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/hup.470070507","article-title":"Recruitment rates and factors affecting recruitment for a trial of a putative anti-psychotic agent in the treatment of schizophrenia.","volume":"7","author":"Bowen","year":"1992","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD004964-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hup.470090605","article-title":"The clinical characteristics of schizophrenic patients consenting or not consenting to a placebo controlled trial of anti-psychotic medication.","volume":"9","author":"Bowen","year":"1994","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD004964-BIB0112|cit112","first-page":"112","article-title":"Threats to the applicability of randomised trials: exclusions and selective participation.","volume":"4","author":"Britton","year":"1999","journal-title":"Journal of Health Services Research"},{"issue":"2","key":"10.1002\/14651858.CD004964-BIB0113|cit113","article-title":"Cochrane Reviewers' Handbook 4.2.0","author":"Clarke","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004964-BIB0114|cit114","first-page":"26","article-title":"Substance abuse and schizophrenia: effects on symptoms but not on neurocognitive function.","volume":"52","author":"Cleghorn","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0115|cit115","first-page":"803","article-title":"Carry-over biases in clinical pharmacology.","volume":"31","author":"Cleophas","year":"1993","journal-title":"European Journal of Clinical Chemistry & Clinical Biochemistry"},{"key":"10.1002\/14651858.CD004964-BIB0116|cit116","first-page":"602","article-title":"Suicide and schizophrenia: data from a prospective community treatment study.","volume":"147","author":"Cohen","year":"1990","journal-title":"Americal Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/sim.1207","article-title":"Meta-analysis combining parallel and cross-over clinical trials III: The issue of carry-over.","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004964-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/sim.1205","article-title":"Meta-analysis combining parallel and cross-over clinical trials I: Continuous outcomes.","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004964-BIB0119|cit119","first-page":"623","article-title":"Drug abuse in schizophrenic patients: clinical correlates and reasons for use.","volume":"7","author":"Dixon","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0120|cit120","first-page":"1041","article-title":"Substance abuse among the chronic mentally ill.","volume":"40","author":"Drake","year":"1989","journal-title":"Hospital and Community Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/schbul\/16.1.57","article-title":"Diagnosis of alcohol disorders in schizophrenia.","volume":"16","author":"Drake","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD004964-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1176\/ajp.148.3.330","article-title":"Housing instability and homelessness among rural schizophrenic patients.","volume":"148","author":"Drake","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004964-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004964-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues.","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004964-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"137-153 137-153","DOI":"10.1207\/S15327574IJT0102_3","article-title":"Improving test quality in the Netherlands: Results of 18 years of test ratings","volume":"1","author":"Evers","year":"2001","journal-title":"International Journal of Testing"},{"key":"10.1002\/14651858.CD004964-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1099-176X(199909)2:3<99::AID-MHP51>3.0.CO;2-C","article-title":"Rational decision-making in mental health: the role of systematic reviews.","volume":"2","author":"Gilbody","year":"1999","journal-title":"Journal of Mental Health Policy and Economics"},{"key":"10.1002\/14651858.CD004964-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.","volume":"149","author":"Gulliford","year":"1999","journal-title":"Americal Journal of Epidemiology"},{"volume-title":"ECDEU Assessment Manual for Psychopharmacology, revised edition.","year":"1976","author":"Guy","key":"10.1002\/14651858.CD004964-BIB0129|cit129"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000440","article-title":"Risperidone versus typical antipsychotic medication for schizophrenia.","author":"Hunter","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004964-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"volume-title":"Randomised Controlled Trials.","year":"1998","author":"Jadad","key":"10.1002\/14651858.CD004964-BIB0132|cit132"},{"key":"10.1002\/14651858.CD004964-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in healthcare. Assessing the quality of controlled clinical trials.","volume":"323","author":"Juni","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004964-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.","volume":"142","author":"Khantzian","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance abuse disorders: a reconsideration and recent applications.","volume":"4","author":"Khantzian","year":"1987","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0136|cit136","first-page":"92","article-title":"Treatment outcome of first episode schizophrenia.","volume":"25","author":"Lieberman","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004964-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia.","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004964-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1191\/026921601678576275","article-title":"Clinical research in palliative care: choice of trial design.","volume":"15","author":"Mazzocato","year":"2001","journal-title":"Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004964-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001473","article-title":"Token economy for schizophrenia.","author":"McMonagle","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004964-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.","volume":"285","author":"Moher","year":"2001","journal-title":"Journal of the American Medical Association,"},{"key":"10.1002\/14651858.CD004964-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1992.tb01441.x","article-title":"Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.","volume":"85","author":"Mueser","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004964-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1001\/jama.287.21.2825","article-title":"Publication bias in editorial decision making.","volume":"287","author":"Olson","year":"2002","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004964-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD004964-BIB0144|cit144","first-page":"2511","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"Journal of the American Academy"},{"key":"10.1002\/14651858.CD004964-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0920-1211(01)00214-5","article-title":"Proof of efficacy trials: cross-over versus parallel-group.","volume":"45","author":"Richens","year":"2001","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD004964-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00005053-198711000-00001","article-title":"A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice.","volume":"175","author":"Schneier","year":"1987","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004964-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials.","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004964-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-199301000-00006","article-title":"Effects of cocaine on hospital course in schizophrenia.","volume":"181","author":"Seibyl","year":"1993","journal-title":"The Journal of Nervous and Mental Disease"},{"volume-title":"Cross-over trials in clinical research: Chichester UK","year":"1993","author":"Senn","key":"10.1002\/14651858.CD004964-BIB0149|cit149"},{"key":"10.1002\/14651858.CD004964-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/096228029900800306","article-title":"Clinical cross-over trials in phase I","volume":"8","author":"Senn","year":"1999","journal-title":"Statistical Methods in Medical Research"},{"issue":"6","key":"10.1002\/14651858.CD004964-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Arch Gen Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004964\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T14:20:34Z","timestamp":1753107634000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004964"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,7,19]]},"references-count":151,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004964","relation":{},"ISSN":["1465-1858"],"issn-type":[{"type":"electronic","value":"1465-1858"}],"subject":[],"published":{"date-parts":[[2004,7,19]]}}}